Delivery Order SPE2DR25D1053-SPE2DR26FV382
- Not listed
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corp a delivery order valued at $2,038.98 for 100 capsules of Adderall XR 30 mg on January 6, 2026, with completion expected by January 7, 2026. This firm fixed-price contract, which was not set aside for any particular business category, represents a task order executed under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves...
- The Defense Logistics Agency awarded a delivery order valued at $1,382.66 to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 20 mg on January 8, 2026, with a completion date of January 9, 2026. This non-set-aside order was competitively awarded on a firm fixed-price basis for delivery to the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,496.00 to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 20 mg. This competitively awarded, firm fixed-price delivery order was issued on December 22, 2025, with an ultimate completion date of December 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,734.09 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (quantity: 100s) on November 7, 2025, with an ultimate completion date of November 10, 2025. The contract employs firm fixed-price pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is listed as Conshohocken, Pennsylvania, which is also the location of AmerisourceBergen's corporate headquarters,...
- The Defense Logistics Agency awarded a delivery order valued at $1,528.74 to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 20 mg on January 6, 2026, with completion targeted for January 7, 2026. This non-set-aside contract utilizes firm fixed-price pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $1,290.28 to AmerisourceBergen Drug Corp for the supply of Adderall XR 10 mg capsules (100-count units) on January 6, 2026, with an ultimate completion date of January 7, 2026. This contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,563.31 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100 count) on January 6, 2026, with an ultimate completion date of January 7, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,131.36 to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 20 mg on December 17, 2025, with a completion date of December 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- On January 9, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,559.51 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100 count). This competitively awarded, firm fixed-price delivery order is scheduled for completion by January 12, 2026, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competition under which it was...
- The Defense Logistics Agency awarded a delivery order valued at $3,718.96 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on December 16, 2025, with completion scheduled for December 17, 2025. This non-competitive, firm fixed-price delivery order represents pharmaceutical procurement for military healthcare needs, with performance at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FV382Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,734.12 to Amerisourcebergen Drug Corp for 100 capsules of Adderall XR 20 mg on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded task order under a larger pharmaceutical supply vehicle. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora, Inc. (doing business as Amerisourcebergen). This delivery order falls under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. This comprehensive IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities. The contract demonstrates the company's established capability to fulfill federal procurement requirements for controlled pharmaceutical substances necessary to support Defense Health Agency operations and other military medical treatment facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/8/26 |